Rapid Alpha

Growth strategy · Due diligence · IP consulting

We're a Growth Advisory Firm that shows you where your next revenue will actually come from.

Rapid Alpha is a growth advisory firm for technical companies from $25M to $150M, many of them PE-backed. In sixteen weeks we find where the growth in your plan actually comes from, run measured experiments and turn it into momentum your team can accelerate.

A gauge for a revenue growth plan: line of sight revenue growth of about eight per cent against a twenty per cent compound annual growth target, leaving a twelve per cent growth gap. Figures are illustrative.
An illustration of the gap we're usually brought in to close.

Results across every industry

Stanley Black & Decker Element3 Boeing Oxa BHP Iluka miRecule Cymotive XTEND

Three client exitsone company exited twice in 90 days

$20M Series Ato take existing technology into new markets

Seven-figure collaborationand investment, for a US market entry

2 acquisitions closed. 1 offer withdrawn.IMDEX’s build-or-buy research ran through to the deals. We did the work a corporate development team would do.

12 R&D programs valuedFor BHP, every program weighed on relative value, with partners found for the ones worth backing and terms negotiated.

Interviews to a signed term sheetOne client's customer interviews became a signed term sheet, a field trial and a grant strategy.

Your growth target has doubled. Your plan isn't ready.

Ten years ago, a company needed about 5% growth a year, a 5% compound annual growth rate (CAGR), to meet its investors' expectations. Today it needs a 10 to 12% CAGR.

Yet most growth plans are still built from market reports, benchmarks and last year's results. Those show where you've been. They don't show which new products, customers or markets will bring in next year's revenue, or how confident you can be in them. That's the gap we close.

Book a working session

Two bars comparing the annual growth a company needed ten years ago, about five per cent, with what it needs today, ten to twelve per cent.
Then: 5% CAGR. Now: 10–12% CAGR. The growth investors expect has doubled.

Source: Bain Global Private Equity Report, 2026.

Growth consulting, backed by evidence

We work in two ways. Some clients want advice: growth strategy and intellectual property consulting. Others want us to act as the corporate development and IP team they haven't built yet. Most use us for both. Other firms call this growth and innovation consulting; we describe it by what you get.

Growth Strategy

We turn your growth number into six to eight tested bets, each with a market, a technology and a way to win.

Learn more

Due Diligence

Technology and IP evidence on a target, inside the deal window: asset purchases, acqui-hires and full company acquisitions.

Learn more

IP Strategy & Management

We read your patents for what they're worth to growth, not just whether they're valid, and build an IP program that supports the plan.

Learn more

Why private equity firms choose Rapid Alpha

We know IP in a way strategy firms don't

We see the growth your patents make possible, and the risks in them.

We stay through the deal

Most advisors stop at the recommendation. We have carried a technology from first customer interviews to a signed term sheet and field trial.

We move fast because our system does the heavy lifting

Our platform, EVOS, gathers and organizes the evidence. Our people extract insights to help you make the right decision for your firm.

Sixteen weeks from a growth number to a plan your operating company can test

Weeks 1–4

Scan

We map the technologies, patents and markets around your business.

Weeks 4–8

Size

We test which markets are real, how big they are and who else is there.

Weeks 8–12

Validate

We talk to customers and run measured experiments.

Weeks 12–16

Decide

You get six to eight scored bets and a clear call on each: advance, hold or stop.

Timeline of Rapid Alpha's sixteen-week method in four phases: scan, size, validate, decide.
Four phases, each ending in a decision.

See the full method

Work we've delivered

Twelve programs to weigh the relative value of R&D efforts, identify strategic partners, and negotiate collaboration and field-trial agreements for technology access.

Read the case

A $20M Series A. XTEND took technology it already had into new markets, and its growth plan held up in front of investors.

Read the case

Commercialized valuable IP through patent sales and exclusive field-of-use licensing, backed by an internal tool for tracking where Boeing wants to transact.

Read the case
Industrial technology company

From customer interviews to a signed term sheet. We tested a new application with real buyers, then stayed through the deal: term sheet, field trial and grant strategy.

Read the case
As we quickly commercialize our best ideas globally, Rapid Alpha continues to be an ideal business partner, brokering introductions with potential partners so we can immediately realize real commercial value.
Matthew SchneiderCEO, Optika Solutions, acquired by Perenti

Is your revenue gap about vision or capability?

The Vision Gap

You know you need to grow, but not where. Too many ideas, no clear way to choose between them.

The Capability Gap

You know where, but not how. The market is clear, but you lack the technology, IP or team to get there.

Most companies have one gap bigger than the other.

Our four-minute diagnostic scores both and shows which one is holding you back.

Take the diagnostic

Start with one company and one hour

Bring one company. In a one-hour working session we'll look at your growth number together, and you'll leave knowing whether we can help.